Porcine Placental Extract Improves the Lipid Profile and Body Weight in a Post-Menopausal Rat Model Without Affecting Reproductive Tissues.

Introduction

What if porcine placental extract (PPE) could combat post-menopausal weight gain and lipid imbalances without the side effects of traditional hormone treatments? The menopause marks a critical shift in women's health, with declining estrogen levels driving increased risks of obesity, metabolic dysfunction, and cardiovascular disease. While hormone replacement therapy remains a common intervention, concerns over its long-term safety have intensified the search for safer alternatives.

Objectives

This study aims to explore the metabolic effects of porcine placental extract (PPE) by using an ovariectomized (OVX) rat model to mimic the hormonal landscape of the menopause.

Methods

Twenty OVX Wistar rats were assigned to either a control group receiving phosphate-buffered saline or a PPE-treated group given intraperitoneal PPE injections for two weeks.

Results

Remarkably, the PPE-treated rats showed significantly lower body weights than the controls. Biochemical analysis revealed that the PPE-treated rats had improved lipid profiles, involving lower total cholesterol and triglyceride levels. Histological examinations of the PPE-treated rats showed no adverse changes in the uterus or mammary glands.

Conclusions

These results highlight PPE's potential as a non-hormonal, tissue-safe intervention for combating weight gain and lipid imbalances in post-menopausal conditions. By promoting lipolysis without impacting reproductive health or muscle mass, PPE opens the door to new possibilities for managing post-menopausal metabolic health. However, further research is needed to determine its long-term efficacy.